Current Ratio of Zentalis Pharmaceuticals, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Zentalis Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 745%, a 0.51% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Zentalis Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 745% -3.8% -0.51% 30 Sep 2025
Q2 2025 735% -53% -6.7% 30 Jun 2025
Q1 2025 701% -190% -21% 31 Mar 2025
Q4 2024 755% -91% -11% 31 Dec 2024
Q3 2024 749% -125% -14% 30 Sep 2024
Q2 2024 788% -62% -7.3% 30 Jun 2024
Q1 2024 891% +73% +9% 31 Mar 2024
Q4 2023 846% +30% +3.7% 31 Dec 2023
Q3 2023 874% +57% +6.9% 30 Sep 2023
Q2 2023 850% -3.2% -0.38% 30 Jun 2023
Q1 2023 818% +14% +1.8% 31 Mar 2023
Q4 2022 816% -48% -5.6% 31 Dec 2022
Q3 2022 817% -142% -15% 30 Sep 2022
Q2 2022 853% -227% -21% 30 Jun 2022
Q1 2022 804% -448% -36% 31 Mar 2022
Q4 2021 864% -338% -28% 31 Dec 2021
Q3 2021 959% -88% -8.4% 30 Sep 2021
Q2 2021 1080% 30 Jun 2021
Q1 2021 1252% 31 Mar 2021
Q4 2020 1203% 31 Dec 2020
Q3 2020 1046% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.